NCCN / Oncology Clinical Protocols
CMF (Cyclophosphamide, Methotrexate, 5-Fluorouracil)
Pharmaceutical companies and oncology drug manufacturers.
CMF (Cyclophosphamide, Methotrexate, 5-Fluorouracil)
CAPOX (Capecitabine, Oxaliplatin)
AC (Doxorubicin (Adriamycin), Cyclophosphamide)
FOLFIRI (Leucovorin, 5-Fluorouracil, Irinotecan)
ADE (Cytarabine (Ara-C), Daunorubicin, Etoposide)
FOLFIRI-CETUXIMAB (Leucovorin, 5-Fluorouracil, Irinotecan, Cetuximab)
CARBOPLATIN-TAXOL (Carboplatin, Paclitaxel)
COPDAC (Cyclophosphamide, Vincristine, Prednisone, Dacarbazine)
COPP (Cyclophosphamide, Vincristine, Procarbazine, Prednisone)
Hyper-CVAD (Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, Dexamethasone alternating with High-Dose Methotrexate and Cytarabine)
ABVE-PC (Doxorubicin, Bleomycin, Vincristine, Etoposide, Prednisone, Cyclophosphamide)
BuMel (Busulfan, Melphalan)